Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 2.7.7.50 - mRNA guanylyltransferase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Adenocarcinoma
??Cyclin D1 protein affecting global women's health by regulating HPV mediated adenocarcinoma of the uterine cervix.
Author Correction: Cyclin D1 protein affecting global women's health by regulating HPV mediated adenocarcinoma of the uterine cervix.
Cyclin D1 protein and CCND1 gene expression in colorectal cancer.
Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis.
Mammalian G1 cyclins.
Polyphenon E inhibits the growth of human Barrett's and aerodigestive adenocarcinoma cells by suppressing cyclin D1 expression.
The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.
[Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues]
Adenoma
Adenoma growth stimulation by the trans-10, cis-12 isomer of conjugated linoleic acid (CLA) is associated with changes in mucosal NF-kappaB and cyclin D1 protein levels in the Min mouse.
Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance.
Berries as chemopreventive dietary constituents--a mechanistic approach with the ApcMin/+ mouse.
Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study.
Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study.
Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis.
Adenomatous Polyps
Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis.
African Swine Fever
African swine fever virus guanylyltransferase.
African swine fever virus NP868R capping enzyme promotes reovirus rescue during reverse genetics by promoting reovirus protein expression, virion assembly, and RNA incorporation into infectious virions.
An Optimized Reverse Genetics System Suitable for Efficient Recovery of Simian, Human, and Murine-Like Rotaviruses.
Expression and characterization of an RNA capping enzyme encoded by Chlorella virus PBCV-1.
Generation of Recombinant Rotavirus Expressing NSP3-UnaG Fusion Protein by a Simplified Reverse Genetics System.
Structure and Biochemical Characteristic of the Methyltransferase (MTase) Domain of RNA Capping Enzyme from African Swine Fever Virus.
Asthma
Anti-Malarial Drug Artesunate Inhibits Primary Human Cultured Airway Smooth Muscle Cell Proliferation.
Barrett Esophagus
Epidemiology and molecular biology of barrett esophagus.
Increased expression of the cyclin D1 gene in Barrett's esophagus.
Bluetongue
Guanylyltransferase and RNA 5'-triphosphatase activities of the purified expressed VP4 protein of bluetongue virus.
Predicted structure and domain organization of rotavirus capping enzyme and innate immune antagonist VP3.
Structure-based identification of functional residues in the nucleoside-2'-O-methylase domain of Bluetongue virus VP4 capping enzyme.
Breast Diseases
Cytologic evaluation of cyclin D1 expression in primary breast carcinoma.
Prolactin does not require insulin-like growth factor intermediates but synergizes with insulin-like growth factor I in human breast cancer cells.
Breast Neoplasms
A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer.
A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes.
A plant oxylipin, 12-oxo-phytodienoic acid, inhibits proliferation of human breast cancer cells by targeting cyclin D1.
A window-of-opportunity biomarker study of etodolac in resectable breast cancer.
Activation of cyclin D1 expression by the ERK5 cascade.
Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclin D1 gene amplification.
AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Analysis of Cyclin D1 in Breast Cancer: A Call to Arms.
Arctiin induces cell growth inhibition through the down-regulation of cyclin D1 expression.
Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information.
Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein.
Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
Cyclin D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen receptor expression.
Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer.
Cyclin D1 and D3 Expression in Vestibular Schwannomas.
Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
Cyclin D1 overexpression in Algerian breast cancer women: correlation with CCND1 amplification and clinicopathological parameters.
Cyclin D1 overexpression is more prevalent in non-Caucasian breast cancer.
Cyclin D1 protein expression and function in human breast cancer.
Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis.
Cyclin D1 protein overexpression and gene amplification in benign breast tissue and breast cancer risk.
Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome.
Cytologic evaluation of cyclin D1 expression in primary breast carcinoma.
Downregulation of Wilms' tumor 1 protein inhibits breast cancer proliferation.
Dysregulated expression of cyclin D1 in normal human mammary epithelial cells inhibits all-trans-retinoic acid-mediated G0/G1-phase arrest and differentiation in vitro.
Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.
Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer.
External imaging of CCND1 cancer gene activity in experimental human breast cancer xenografts with 99mTc-peptide-peptide nucleic acid-peptide chimeras.
External Imaging of CCND1, MYC, and KRAS Oncogene mRNAs with Tumor-Targeted Radionuclide-PNA-Peptide Chimeras.
Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast.
Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers.
High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer.
IGF-1R promotes the expression of cyclin D1 protein and accelerates the G1/S transition by activating Ras/Raf/MEK/ERK signaling pathway.
LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer.
Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein.
Mechanism of cell cycle regulation by FIP200 in human breast cancer cells.
Nuclear loss of protein arginine N-methyltransferase 2 in breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein.
PLD1 is overexpressed in an ER-negative MCF-7 cell line variant and a subset of phospho-Akt-negative breast carcinomas.
Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
Prolactin does not require insulin-like growth factor intermediates but synergizes with insulin-like growth factor I in human breast cancer cells.
Regulation of cyclin D1 by calpain protease.
Salicylate suppresses the oncogenic hyaluronan network in metastatic breast cancer cells.
Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
Slug-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination.
The involvement of cyclin D1 degradation through GSK3?-mediated threonine-286 phosphorylation-dependent nuclear export in anti-cancer activity of mulberry root bark extracts.
The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours.
Translational regulation of cyclin D1 by 15-deoxy-delta(12,14)-prostaglandin J(2).
[Expression and Significance of BP1 Gene and Cyclin D1 Gene in Breast Cancer.]
[Expression of PTEN protein and its correlation with p27kip1 and cyclin D1 expression in primary breast cancer]
Carcinogenesis
Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation.
Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis.
Cyclin D1 protein expression in lung cancer.
Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast.
Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma.
Dual role for Id2 in chemical carcinogen-induced skin tumorigenesis.
Dysregulated expression of cyclin D1 in normal human mammary epithelial cells inhibits all-trans-retinoic acid-mediated G0/G1-phase arrest and differentiation in vitro.
Early overexpression of cyclin D1 protein in mouse skin carcinogenesis.
Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma.
IGF-1R promotes the expression of cyclin D1 protein and accelerates the G1/S transition by activating Ras/Raf/MEK/ERK signaling pathway.
Immunohistochemical expression of cell-cycle proteins in gastric precancerous lesions.
Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis.
Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
Molecular pathology of the cell cycle in human cancer cells.
Mouse mammary hyperplasias and neoplasias exhibit different patterns of cyclins D1 and D2 binding to cdk4.
Overexpression of cyclin D1 in nonmelanocytic skin cancer.
p53 and cyclin D1 protein expression in glottic laryngeal squamous cell carcinomas involving the anterior commissure (pT1bN0M0).
[Role of cyclin D1 protein, p53 protein and DNA ploidy in judging malignancy and prognosis of lung cancer.]
[The expression of p53, cyclin D1 and PCNA in non-small cell lung cancer.]
Carcinoma
Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation.
Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance.
Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus.
Alternate paths from epidermal growth factor receptor to Akt in malignant versus nontransformed lung epithelial cells: ErbB3 versus Gab1.
An immunohistochemical study of cyclin D1 protein expression in laryngeal squamous cell carcinoma.
Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors.
Analysis of p53 mutation and cyclin D1 expression in breast tumors.
Association between high initial tissue levels of cyclin d1 and recurrence of nasopharyngeal carcinoma.
Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma.
Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation.
Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
Cyclin D1 gene expression in human cervical neoplasia.
Cyclin D1 in oral premalignant lesions and oral squamous cell carcinoma: An immunohistochemical study.
Cyclin D1 overexpression associated with activation of STAT3 in oral carcinoma patients from South India.
Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Cyclin D1 protein expression in lung cancer.
Cyclin D1 protein expression is related to clinical progression in laryngeal squamous cell carcinomas.
Cyclin D1 protein overexpression is related to tumor differentiation, but not to tumor progression or proliferative activity, in transitional cell carcinoma of the bladder.
Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context.
Enhanced tumor formation in cyclin D1 x transforming growth factor beta1 double transgenic mice with characterization by magnetic resonance imaging.
Expression of cyclin D1 correlates with malignancy in human ovarian tumours.
Human papillomavirus, p53 and cyclin D1 expression in oropharyngeal carcinoma.
Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.
Lack of cyclin D1 overexpression in gastric carcinogenesis.
Mammalian G1 cyclins.
Numerical abnormalities of the Cyclin D1 gene locus on chromosome 11q13 in non-melanoma skin cancer.
Overexpressed cyclin D1 protein related to p53 and retinoblastoma proteins in transitional cell carcinoma of the urinary tract.
Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.
Overexpression of cyclin D1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach.
p53 and cyclin D1 protein expression in glottic laryngeal squamous cell carcinomas involving the anterior commissure (pT1bN0M0).
p53 and cyclinX D1 protein expression in carcinomas of the parotid gland.
The expression of AEG-1 and Cyclin D1 in human bladder urothelial carcinoma and their clinicopathological significance.
[Cyclin D1 overexpression in laryngeal carcinomas]
[Effect of cyclin D1 protein expression on the prognosis of esophageal squamous-cell carcinoma treated with preoperative radiotherapy]
[Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues]
[The expression of P16, P21(WAF1/CIP1) and Cyclin D1 proteins in skin of patients with arseniasis caused by coal-burning and their significance]
[The expressions of telomerase activity and cyclinD1 protein in laryngeal squamous cell carcinoma]
Carcinoma, Basal Cell
Numerical abnormalities of the Cyclin D1 gene locus on chromosome 11q13 in non-melanoma skin cancer.
Carcinoma, Ductal
Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
p27KIP-1, cyclin A and cyclin D1 protein expression in ductal carcinoma in situ of the breast: p27KIP-1 correlates with hormone receptor status but not with local recurrence.
[Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection]
Carcinoma, Hepatocellular
Cyclin D1 overexpression in hepatocellular carcinoma.
Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer.
Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
The involvement of cyclin D1 degradation through GSK3?-mediated threonine-286 phosphorylation-dependent nuclear export in anti-cancer activity of mulberry root bark extracts.
Carcinoma, Intraductal, Noninfiltrating
Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast.
Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast.
Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast.
p27KIP-1, cyclin A and cyclin D1 protein expression in ductal carcinoma in situ of the breast: p27KIP-1 correlates with hormone receptor status but not with local recurrence.
Carcinoma, Lobular
Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information.
Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast.
Carcinoma, Ovarian Epithelial
Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells.
Carcinoma, Squamous Cell
Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation.
Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus.
Association between high initial tissue levels of cyclin d1 and recurrence of nasopharyngeal carcinoma.
Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation.
Cyclin D1 gene expression in human cervical neoplasia.
Cyclin D1 protein expression is related to clinical progression in laryngeal squamous cell carcinomas.
Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context.
Human papillomavirus, p53 and cyclin D1 expression in oropharyngeal carcinoma.
Numerical abnormalities of the Cyclin D1 gene locus on chromosome 11q13 in non-melanoma skin cancer.
Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.
p53 and cyclin D1 protein expression in glottic laryngeal squamous cell carcinomas involving the anterior commissure (pT1bN0M0).
[The expressions of telomerase activity and cyclinD1 protein in laryngeal squamous cell carcinoma]
Carcinoma, Transitional Cell
Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Cyclin D1 protein overexpression is related to tumor differentiation, but not to tumor progression or proliferative activity, in transitional cell carcinoma of the bladder.
Overexpressed cyclin D1 protein related to p53 and retinoblastoma proteins in transitional cell carcinoma of the urinary tract.
Chikungunya Fever
The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection.
Cholangiocarcinoma
Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
Choriocarcinoma
Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis.
Colitis
Differential regulation of D-type cyclins in the mouse intestine.
Colonic Neoplasms
Antitumor bicyclic hexapeptide RA-VII modulates cyclin D1 protein level.
Functional characterization of peroxisome proliferator-activated receptor-?/? expression in colon cancer.
MicroRNA?25/ATXN3 interaction regulates human colon cancer cell growth and migration.
The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas.
Colorectal Neoplasms
Analysis of key cell-cycle checkpoint proteins in colorectal tumours.
Anti-cancer activity of
Cyclin D1 overexpression in colorectal carcinoma in vivo is dependent on beta-catenin protein dysregulation, but not k-ras mutation.
Cyclin D1 protein and CCND1 gene expression in colorectal cancer.
Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative.
p53 inhibits adriamycin-induced down-regulation of cyclin D1 expression in human cancer cells.
Subcellular localisation of cyclin D1 protein in colorectal tumours is associated with p21(WAF1/CIP1) expression and correlates with patient survival.
The involvement of cyclin D1 degradation through GSK3?-mediated threonine-286 phosphorylation-dependent nuclear export in anti-cancer activity of mulberry root bark extracts.
The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas.
Thymidylate synthase and cyclin d1 protein expression in lymph node negative colorectal cancer: role as prognostic factors?
TREM2 Acts as a Tumor Suppressor in Colorectal Carcinoma through Wnt1/?-catenin and Erk Signaling.
Dehydration
Effects of drought stress on photosynthesis and photosynthetic electron transport chain in young apple tree leaves.
Operation of the xanthophyll cycle and degradation of D1 protein in the inducible CAM plant, Talinum triangulare, under water deficit.
Weak red light plays an important role in awakening the photosynthetic machinery following desiccation in the subaerial cyanobacterium Nostoc flagelliforme.
Dengue
Analysis of RNA binding by the dengue virus NS5 RNA capping enzyme.
Glutathionylation of dengue and Zika NS5 proteins affects guanylyltransferase and RNA dependent RNA polymerase activities.
Identification of a novel antiviral inhibitor of the flavivirus guanylyltransferase enzyme.
Murine Efficacy and Pharmacokinetic Evaluation of the Flaviviral NS5 Capping Enzyme 2-Thioxothiazolidin-4-One Inhibitor BG-323.
Dysarthria
A mutation in the THG1L gene in a family with cerebellar ataxia and developmental delay.
Encephalomyelitis, Venezuelan Equine
Approved drugs screening against the nsP1 capping enzyme of Venezuelan equine encephalitis virus using an immuno-based assay.
Esophageal Neoplasms
Overexpression of cyclin DI contributes to malignant properties of esophageal tumor cells by increasing VEGF production and decreasing Fas expression.
p53, p21(Waf1/Cip1) and cyclin D1 protein expression and prognosis in esophageal cancer.
The prognostic significance of p53, p21 (Waf1/Cip1), and cyclin D1 protein expression in esophageal cancer patients.
Fibromatosis, Aggressive
Intrathoracic sporadic desmoid tumor with the beta-catenin gene mutation in exon 3 and activated cyclin D1.
Fibrosarcoma
Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.
Gastrointestinal Stromal Tumors
[Expression and clinical significance of p27 protein and cyclinD1 protein in gastrointestinal stromal tumors]
Giant Cell Tumors
Cyclin D1 and p21 is elevated in the giant cells of giant cell tumors.
Glioblastoma
Adrenomedullin promotes cell cycle transit and up-regulates cyclin D1 protein level in human glioblastoma cells through the activation of c-Jun/JNK/AP-1 signal transduction pathway.
Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray.
Glioma
Antiproliferative action of neomycin is associated with inhibition of cyclin D1 activation in glioma cells.
Differential regulation of cdk2 and cyclin D1 in irradiated human glioma cells.
The glutamine antagonist prodrug JHU-083 slows malignant glioma growth and disrupts mTOR signaling.
Glomerulonephritis, Membranous
Differential expression of d-type cyclins in podocytes in vitro and in vivo.
Granuloma
Central giant cell granuloma of the jaws: assessment of cell cycle proteins.
Granuloma, Giant Cell
Central giant cell granuloma of the jaws: assessment of cell cycle proteins.
Head and Neck Neoplasms
Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.
Heart Neoplasms
Correlation of p16 and cyclin D1 expression with the incidence and prognosis of cardiac carcinoma.
Hematologic Neoplasms
Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma.
Hepatitis E
Virus-specific mRNA capping enzyme encoded by hepatitis E virus.
Herpes Simplex
Nucleotide sequence of a 55 kbp region from the right end of the genome of a pathogenic African swine fever virus isolate (Malawi LIL20/1).
Hodgkin Disease
[The expression of p42/p44MAPK and cyclin D1 protein and their relationship in Hodgkin's disease]
Infections
A Sensitive and Robust High-Throughput Screening Assay for Inhibitors of the Chikungunya Virus nsP1 Capping Enzyme.
HEPATITIS C VIRUS CORE PROTEIN MODULATES ENDOGLIN (CD105) SIGNALING PATHWAY FOR LIVER PATHOGENESIS.
Influence of stripe rust infection on the photosynthetic characteristics and antioxidant system of susceptible and resistant wheat cultivars at the adult plant stage.
iTRAQ protein profile analysis provides integrated insight into mechanisms of tolerance to TMV in tobacco (Nicotiana tabacum).
p53 inhibits adriamycin-induced down-regulation of cyclin D1 expression in human cancer cells.
Photosynthesis genes in marine viruses yield proteins during host infection.
Regulation of host cell cyclin D1 by Trypanosoma cruzi in myoblasts.
[Effects of Pseudomonas syringae pv. tabaci infection on tobacco photosynthetic apparatus under light or dark conditions.]
Laryngeal Neoplasms
Cyclin D1 protein tissue detection in laryngeal cancer.
Prognostic significance of cyclin D1 protein levels in early-stage larynx cancer treated with primary radiation.
Leukemia
Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow.
Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded tissue sections.
The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.
Leukemia, B-Cell
BCL-1 rearrangement in acute lymphocytic leukemia and its clinical significance.
Leukemia, Hairy Cell
Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow.
Leukemia, Lymphoid
Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow.
Leukemia, Myeloid
BCL-1 rearrangement in acute lymphocytic leukemia and its clinical significance.
Leukemia, Myeloid, Acute
Cyclin D1 expression in acute leukemia.
Leukemia, Plasma Cell
Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded tissue sections.
Lung Neoplasms
Cyclin D1 blocks the anti-proliferative function of RUNX3 by interfering with RUNX3-p300 interaction.
Cyclin D1 protein expression in lung cancer.
Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.
Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancers.
Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells.
[Role of cyclin D1 protein, p53 protein and DNA ploidy in judging malignancy and prognosis of lung cancer.]
Lymphatic Metastasis
Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance.
Correlation of p16 and cyclin D1 expression with the incidence and prognosis of cardiac carcinoma.
Cyclin D1 Overexpression and Poor Clinical Outcomes in Taiwanese Oral Cavity Squamous Cell Carcinoma.
Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway.
Molecular and immunohistochemical analysis of the bcl-1/cyclin D1 gene in laryngeal squamous cell carcinomas: correlation of protein expression with lymph node metastases and advanced clinical stage.
Overexpression of cyclin D1 and interaction between p27Kip1 and tumour thickness predict lymph node metastases occurrence in lower lip squamous cell carcinoma.
Lymphoma
A Multi-target Drug Designing for BTK, MMP9, Proteasome and TAK1 for the Clinical Treatment of Mantle Cell Lymphoma.
Aberrant CCND1 copies and cyclin D1 mRNA expression do not result in the production of functional cyclin D1 protein in anaplastic large cell lymphoma.
Absence of cyclin D1 protein expression in splenic marginal zone lymphoma.
bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma.
Catalyzed signal amplification for cyclin D1 detection in mantle cell lymphoma.
Clinicopathologic study of primary gastric lymphoma of B cell phenotype with special reference to low-grade B cell lymphoma of mucosa-associated lymphoid tissue among the Japanese.
Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma.
Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity.
Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry.
Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma.
Cyclin D1 protein expression in mantle cell lymphoma.
Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.
Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray.
Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene.
Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine.
Expression of LMP-1 and Cyclin D1 protein is correlated with an unfavorable prognosis in nasal type NK/T cell lymphoma.
GSK-3beta inhibition: at the crossroad between Akt and mTOR constitutive activation to enhance cyclin D1 protein stability in mantle cell lymphoma.
Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma.
Immunostaining of PRAD1/cyclin D1 protein as a marker for the diagnosis of mantle cell lymphoma.
Instances of mantle cell lymphoma morphologically mimicking other subtypes of B-cell lymphoid proliferation.
Intranuclear expression of cyclin D1 protein as a useful prognostic marker for mantle cell lymphoma.
Mammalian G1 cyclins.
MicroRNA?214 suppresses propofol?induced neuroapoptosis through activation of phosphoinositide 3?kinase/protein kinase B signaling by targeting phosphatase and tensin homolog expression.
Morphologic diagnosis of leukaemic B-lymphoproliferative disorders and the role of cyclin D1 expression.
Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells.
The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index.
What Is Responsible for Heterogeneity in Mantle Cell Lymphoma Biology and Outcomes?
[Detection of cyclin D1 protein expression and t(11;14) chromosomal translocation in paraffin-embedded tissues and its clinicopathologic significance for mantle cell lymphoma]
[Significance of phosphorylation of mitogen-activated protein kinase and signal transducer and activator of transcription 3 and cyclin D1 protein expression in Hodgkin's lymphomas]
Lymphoma, B-Cell
Clinicopathologic study of primary gastric lymphoma of B cell phenotype with special reference to low-grade B cell lymphoma of mucosa-associated lymphoid tissue among the Japanese.
Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia.
Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry.
Mantle cell lymphoma.
Primary large B-cell lymphoma of the central nervous system with cyclin D1 expression and t(11;14) (IGH-CCND1): Diffuse large B-cell lymphoma with CCND1 rearrangement or mantle cell lymphoma?
Splenic B-Cell Lymphomas with Diffuse Cyclin D1 Protein Expression and Increased Prolymphocytic Cells: A Previously Unrecognized Diagnostic Pitfall.
[Expression of CD68, cyclin D1 and rearrangement of bcl-6 gene are adverse prognostic factors in diffuse large B-cell lymphoma].
Lymphoma, Large B-Cell, Diffuse
[Expression of CD68, cyclin D1 and rearrangement of bcl-6 gene are adverse prognostic factors in diffuse large B-cell lymphoma].
Lymphoma, Large-Cell, Anaplastic
Aberrant CCND1 copies and cyclin D1 mRNA expression do not result in the production of functional cyclin D1 protein in anaplastic large cell lymphoma.
Lymphoma, Mantle-Cell
A Multi-target Drug Designing for BTK, MMP9, Proteasome and TAK1 for the Clinical Treatment of Mantle Cell Lymphoma.
Absence of cyclin D1 protein expression in splenic marginal zone lymphoma.
bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma.
Catalyzed signal amplification for cyclin D1 detection in mantle cell lymphoma.
Clinicopathologic study of primary gastric lymphoma of B cell phenotype with special reference to low-grade B cell lymphoma of mucosa-associated lymphoid tissue among the Japanese.
Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma.
Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma.
Cyclin D1 protein expression in mantle cell lymphoma.
Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine.
GSK-3beta inhibition: at the crossroad between Akt and mTOR constitutive activation to enhance cyclin D1 protein stability in mantle cell lymphoma.
Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma.
Immunostaining of PRAD1/cyclin D1 protein as a marker for the diagnosis of mantle cell lymphoma.
Instances of mantle cell lymphoma morphologically mimicking other subtypes of B-cell lymphoid proliferation.
Intranuclear expression of cyclin D1 protein as a useful prognostic marker for mantle cell lymphoma.
Morphologic diagnosis of leukaemic B-lymphoproliferative disorders and the role of cyclin D1 expression.
Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells.
The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index.
What Is Responsible for Heterogeneity in Mantle Cell Lymphoma Biology and Outcomes?
[Detection of cyclin D1 protein expression and t(11;14) chromosomal translocation in paraffin-embedded tissues and its clinicopathologic significance for mantle cell lymphoma]
Lymphoma, Non-Hodgkin
A Multi-target Drug Designing for BTK, MMP9, Proteasome and TAK1 for the Clinical Treatment of Mantle Cell Lymphoma.
Cyclin Dl expression in B-cell non Hodgkin lymphoma.
Lymphoproliferative Disorders
Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entity.
Cyclin D1 protein expression in mantle cell lymphoma.
Ectopic expression of cyclin D1 impairs the proliferation and enhances the apoptosis of a murine lymphoid cell line.
Measles
Signature motifs of GDP polyribonucleotidyltransferase, a non-segmented negative strand RNA viral mRNA capping enzyme, domain in the L protein are required for covalent enzyme-pRNA intermediate formation.
Melanoma
Additional Cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma.
An update on the implications of cyclin D1 in melanomas.
Arctiin induces cell growth inhibition through the down-regulation of cyclin D1 expression.
CCND1 copy number increase and cyclin D1 expression in acral melanoma: a comparative study of fluorescence in situ hybridization and immunohistochemistry in a Chinese cohort.
Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray.
Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.
Mammalian G1 cyclins.
Role of ROC1 protein in the control of cyclin D1 protein expression in skin melanomas.
Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells.
The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma.
The role of cyclin D1 and Ki-67 in the development and prognostication of thin melanoma.
Microcephaly
Coordinate control of cell cycle regulatory genes in zebrafish development tested by cyclin D1 knockdown with morpholino phosphorodiamidates and hydroxyprolyl-phosphono peptide nucleic acids.
Multiple Myeloma
Bcl-1 rearrangement and cyclin D1 protein expression in multiple myeloma precursor cells.
Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded tissue sections.
The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study.
Myocardial Infarction
Compatibility of Astragalus and Salvia extract inhibits myocardial fibrosis and ventricular remodeling by regulation of protein kinase D1 protein.
Neoplasm Metastasis
Additional Cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma.
Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance.
Correlation of p16 and cyclin D1 expression with the incidence and prognosis of cardiac carcinoma.
Cyclin D1 Overexpression and Poor Clinical Outcomes in Taiwanese Oral Cavity Squamous Cell Carcinoma.
Cyclin D1 protein expression is related to clinical progression in laryngeal squamous cell carcinomas.
Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway.
HEPATITIS C VIRUS CORE PROTEIN MODULATES ENDOGLIN (CD105) SIGNALING PATHWAY FOR LIVER PATHOGENESIS.
Impact of cyclin D1 A870G polymorphism in esophageal adenocarcinoma tumorigenesis.
Molecular and immunohistochemical analysis of the bcl-1/cyclin D1 gene in laryngeal squamous cell carcinomas: correlation of protein expression with lymph node metastases and advanced clinical stage.
Overexpression of cyclin D1 and interaction between p27Kip1 and tumour thickness predict lymph node metastases occurrence in lower lip squamous cell carcinoma.
p53 and cyclin D1 protein expression in glottic laryngeal squamous cell carcinomas involving the anterior commissure (pT1bN0M0).
Neoplasm, Residual
Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer.
Neoplasms
3'UTR mediated regulation of the cyclin D1 proto-oncogene.
A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.
A genotype-phenotype examination of cyclin D1 on risk and outcome of squamous cell carcinoma of the head and neck.
A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes.
Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus.
Absence of cyclin D1 protein expression in splenic marginal zone lymphoma.
Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.
Alterations of the CCND1 and HER-2/neu (ERBB2) proteins in esophageal and gastric cancers.
Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer.
Altered gene expression in spontaneous hepatocellular carcinomas from male B6C3F1 mice.
Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas.
Amplification of cyclin D1 and MDM-2 in oesophageal carcinoma.
Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression.
Analysing the Effect of Mutation on Protein Function and Discovering Potential Inhibitors of CDK4: Molecular Modelling and Dynamics Studies.
Analysis of Cyclin D1 in Breast Cancer: A Call to Arms.
Antiproliferative and proapoptotic activity of CLM3, a novel multiple tyrosine kinase inhibitor, alone and in combination with SN-38 on endothelial and cancer cells.
Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas.
Antitumor activity of potent pyruvate dehydrogenase kinase 4 inhibitors from plants in pancreatic cancer.
Apoptotic and proliferative markers in chordomas: a study of 26 tumors.
Arctiin induces cell growth inhibition through the down-regulation of cyclin D1 expression.
Association between high initial tissue levels of cyclin d1 and recurrence of nasopharyngeal carcinoma.
BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation.
Benzophenone-1 stimulated the growth of BG-1 ovarian cancer cells by cell cycle regulation via an estrogen receptor alpha-mediated signaling pathway in cellular and xenograft mouse models.
Betulinic acid selectively increases protein degradation and enhances prostate cancer-specific apoptosis: possible role for inhibition of deubiquitinase activity.
Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma.
CCND1 Splice Variant as A Novel Diagnostic and Predictive Biomarker for Thyroid Cancer.
Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein.
Correlation of beta-catenin and cyclin D1 expression in colon cancers.
Correlation of p16 and cyclin D1 expression with the incidence and prognosis of cardiac carcinoma.
Cyclin D and cisplatin cytotoxicity in primary neuroblastoma cell lines.
Cyclin D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen receptor expression.
Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development.
Cyclin D1 and p21 is elevated in the giant cells of giant cell tumors.
Cyclin D1 expression does not effect cell proliferation in adenoid cystic carcinoma of the salivary gland.
Cyclin D1 expression in acute leukemia.
Cyclin D1 expression in astrocytomas is associated with cell proliferation activity and patient prognosis.
Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast.
Cyclin D1 gene expression in human cervical neoplasia.
Cyclin D1 gene polymorphism, A870G, is associated with an increased risk of salivary gland tumors in the Chinese population.
Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow.
Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway.
Cyclin D1 overexpression and p53 mutation status in epithelial ovarian cancer.
Cyclin D1 Overexpression and Poor Clinical Outcomes in Taiwanese Oral Cavity Squamous Cell Carcinoma.
Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
Cyclin D1 overexpression in hepatocellular carcinoma.
Cyclin D1 protein expression and function in human breast cancer.
Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative.
Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded tissue sections.
Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast.
Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines.
Cyclin D1 protein overexpression is related to tumor differentiation, but not to tumor progression or proliferative activity, in transitional cell carcinoma of the bladder.
Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling.
Cyclin Dl expression in B-cell non Hodgkin lymphoma.
Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway.
Cytotoxic and antimigratory effects of Cratoxy formosum extract against HepG2 liver cancer cells.
Damnacanthal and its nanoformulation exhibit anti-cancer activity via cyclin D1 down-regulation.
Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors.
Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma.
Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression.
Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.
Dual role for Id2 in chemical carcinogen-induced skin tumorigenesis.
Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification.
Dysregulated expression of cyclin D1 in normal human mammary epithelial cells inhibits all-trans-retinoic acid-mediated G0/G1-phase arrest and differentiation in vitro.
Early overexpression of cyclin D1 protein in mouse skin carcinogenesis.
Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.
Effect of Liuweidihuang pill and Jinkuishenqi pill on inhibition of spontaneous breast carcinoma growth in mice.
Effects of Auraptene on IGF-1 Stimulated Cell Cycle Progression in the Human Breast Cancer Cell Line, MCF-7.
Epidemiology and molecular biology of barrett esophagus.
Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancers.
Ethanol extracts from the branch of Taxillus yadoriki parasitic to Neolitsea sericea induces cyclin D1 proteasomal degradation through cyclin D1 nuclear export.
Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells.
Expression levels of eIF4E, VEGF, and cyclin D1, and correlation of eIF4E with VEGF and cyclin D1 in multi-tumor tissue microarray.
Expression of cyclin D1 correlates with malignancy in human ovarian tumours.
Expression of cyclin D1, cyclin E, cdk4 and loss of heterozygosity of 8p, 13q, 17p in hepatocellular carcinoma: comparison study of childhood and adult hepatocellular carcinoma.
Expression of cyclin Ds in relation to p53 status in human breast carcinomas.
Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine.
Expression of p16 and cyclin D1 in bladder cancer and correlation in cancer progression.
Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.
Frequent overexpression of cyclin D1 in sporadic pancreatic endocrine tumours.
Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast.
Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers.
HEPATITIS C VIRUS CORE PROTEIN MODULATES ENDOGLIN (CD105) SIGNALING PATHWAY FOR LIVER PATHOGENESIS.
High-Refined-Carbohydrate and High-Fat Diets Induce Comparable Hepatic Tumorigenesis in Male Mice.
Immunohistochemical expression of cyclin D1 is higher in supratentorial ependymomas and predicts relapses in gross total resection cases.
Impact of cyclin D1 A870G polymorphism in esophageal adenocarcinoma tumorigenesis.
In-depth analysis of molecular alterations within normal and tumour tissue from an entire bronchial tree.
Increased signal transducer and activator of transcription 3 (STAT3) and decreased cyclin D1 in recurrent astrocytic tumours compared with paired primary astrocytic tumours.
Inhibition of PHLPP2/cyclin D1 protein translation contributes to the tumor suppressive effect of NF?B2 (p100).
Investigation of the Inhibitory Effect of Platycodin D in Human Transitional Cell Carcinoma Cell Line 5637.
LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer.
Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein.
Mammalian G1 cyclins.
Maple polyphenols, ginnalins A-C, induce S- and G2/M-cell cycle arrest in colon and breast cancer cells mediated by decreasing cyclins A and D1 levels.
Molecular epidemiology and phylogenetic analysis of a marine fish infectious spleen and kidney necrosis virus-like (ISKNV-like) virus.
Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): potential role of cyclin D1.
No difference in CCND1 gene expression between breast cancer patients with and without lymph node metastasis in a Southern Brazilian sample.
Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
Nuclear loss of protein arginine N-methyltransferase 2 in breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein.
Oral contraceptive use and cyclin D1 overexpression in breast cancer among young women.
Overexpressed cyclin D1 protein related to p53 and retinoblastoma proteins in transitional cell carcinoma of the urinary tract.
Overexpression of cyclin D1 and interaction between p27Kip1 and tumour thickness predict lymph node metastases occurrence in lower lip squamous cell carcinoma.
Overexpression of cyclin D1 in nonmelanocytic skin cancer.
Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.
Overexpression of cyclin DI contributes to malignant properties of esophageal tumor cells by increasing VEGF production and decreasing Fas expression.
PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer.
Polymorphisms in cyclin D1 gene and hepatocellular carcinoma.
Preparation and characterization of withaferin A loaded pegylated nanoliposomal formulation with high loading efficacy: In vitro and in vivo anti-tumour study.
Prognostic significance of surgical margin, Ki-67 and cyclin D1 protein expression in grade II canine cutaneous mast cell tumor.
Progression of Breast Cancer Cells Was Enhanced by Endocrine-Disrupting Chemicals, Triclosan and Octylphenol, via an Estrogen Receptor-Dependent Signaling Pathway in Cellular and Mouse Xenograft Models.
Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
Quercetin, a natural dietary flavonoid, acts as a chemopreventive agent against prostate cancer in an in vivo model by inhibiting the EGFR signaling pathway.
Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide.
Rho-kinase regulates negatively the epidermal growth factor-stimulated colon cancer cell proliferation.
RNA capping by HeLa cell RNA guanylyltransferase. Characterization of a covalent protein-guanylate intermediate.
Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells.
siRNA blocking the RAS signalling pathway and inhibits the growth of oesophageal squamous cell carcinoma in nude mice.
SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors.
Suberoylanilide hydroxamic acid (SAHA) inhibits EGF-induced cell transformation via reduction of cyclin D1 mRNA stability.
Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo.
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.
The ATM and ATR inhibitors CGK733 and caffeine suppress cyclin D1 levels and inhibit cell proliferation.
The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression.
The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer.
The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
Thymidylate synthase and cyclin d1 protein expression in lymph node negative colorectal cancer: role as prognostic factors?
Tongue cancer in younger patients.
Translocation (11;14)(q13;q32) and overexpression of cyclin D1 protein in a CD23-positive low-grade B-cell neoplasm.
X-linked inhibitor of apoptosis protein (XIAP) regulation of cyclin D1 protein expression and cancer cell anchorage-independent growth via its E3 ligase-mediated protein phosphatase 2A/c-Jun axis.
[Effect of cyclin D1 protein expression on the prognosis of esophageal squamous-cell carcinoma treated with preoperative radiotherapy]
[Expression and clinical significance of p27 protein and cyclinD1 protein in gastrointestinal stromal tumors]
[Expression of Pin1, beta-catenin and cyclin D1 in salivary adenoid cystic carcinoma and its significance]
[Loss of CDKN2 gene and amplification of cyclin D1 gene in human esophageal cancer]
[Role of cyclin D1 protein, p53 protein and DNA ploidy in judging malignancy and prognosis of lung cancer.]
[The expressions of telomerase activity and cyclinD1 protein in laryngeal squamous cell carcinoma]
Neoplasms, Plasma Cell
Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded tissue sections.
Neuroblastoma
Antiproliferative and cytotoxic effects of resveratrol in mitochondria-mediated apoptosis in rat b103 neuroblastoma cells.
Neurofibrosarcoma
The prognostic value of C-X-C motif chemokine receptor 4 in patients with sporadic malignant peripheral nerve sheath tumors.
Neuroma, Acoustic
Cyclin D1 and D3 Expression in Vestibular Schwannomas.
Osteosarcoma
Arctiin induces cell growth inhibition through the down-regulation of cyclin D1 expression.
Clinical significance of the phosphorylation of MAPK and protein expression of cyclin D1 in human osteosarcoma tissues.
Honokiol induces autophagy and apoptosis of osteosarcoma through PI3K/Akt/mTOR signaling pathway.
Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells.
Ovarian Neoplasms
Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression.
Paget Disease, Extramammary
Expression of phosphorylated Stat3, cyclin D1 and Bcl-xL in extramammary Paget disease.
Pancreatic Neoplasms
Intratumoral delivery of shRNA targeting cyclin D1 attenuates pancreatic cancer growth.
Papilloma
Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Parathyroid Neoplasms
Cyclin D1 in parathyroid disease.
Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study.
Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study.
Photophobia
Engineering of the protein environment around the redox-active TyrZ in photosystem II. The role of F186 and P162 in the D1 protein of Synechocystis 6803.
Photosensitivity Disorders
Photodynamic effect of iron excess on photosystem II function in pea plants.
Plasmacytoma
Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded tissue sections.
Cyclin D1 protein overexpression in extramedullary plasmacytoma: a clinicopathologic study of 11 cases.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
BCL-1 rearrangement in acute lymphocytic leukemia and its clinical significance.
Cyclin D1 expression in acute leukemia.
Prostatic Neoplasms
A Reduction in Pten Tumor Suppressor Activity Promotes ErbB-2-Induced Mouse Prostate Adenocarcinoma Formation through the Activation of Signaling Cascades Downstream of PDK1.
Arctiin induces cell growth inhibition through the down-regulation of cyclin D1 expression.
Betulinic acid selectively increases protein degradation and enhances prostate cancer-specific apoptosis: possible role for inhibition of deubiquitinase activity.
Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors.
Methyl 2-cyano-3,11-dioxo-18 beta-olean-1,12-dien-30-oate is a peroxisome proliferator-activated receptor-gamma agonist that induces receptor-independent apoptosis in LNCaP prostate cancer cells.
Tissue-specific consequences of cyclin D1 overexpression in prostate cancer progression.
Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo.
Protein-Energy Malnutrition
Immunohistochemical examination of the INK4 and Cip inhibitors in the rat neonatal cerebellum: cellular localization and the impact of protein calorie malnutrition.
Pseudolymphoma
Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia.
Rabies
A dual-functional priming-capping loop of rhabdoviral RNA polymerases directs terminal de novo initiation and capping intermediate formation.
Signature motifs of GDP polyribonucleotidyltransferase, a non-segmented negative strand RNA viral mRNA capping enzyme, domain in the L protein are required for covalent enzyme-pRNA intermediate formation.
Rectal Neoplasms
Synergistic effects of AKAP95, Cyclin D1, Cyclin E1, and Cx43 in the development of rectal cancer.
Retinoblastoma
Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.
Beta2-adrenergic receptor agonists and cAMP arrest human cultured airway smooth muscle cells in the G(1) phase of the cell cycle: role of proteasome degradation of cyclin D1.
Ceramide 1-phosphate stimulates proliferation of C2C12 myoblasts.
Control of cyclin D1, p27(Kip1), and cell cycle progression in human capillary endothelial cells by cell shape and cytoskeletal tension.
Cyclin D1 protein expression and function in human breast cancer.
Deletion of Methionine Sulfoxide Reductase A Does Not Affect Atherothrombosis but Promotes Neointimal Hyperplasia and Extracellular Signal-Regulated Kinase 1/2 Signaling.
E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1).
Establishment of a novel melanoma cell line SMYM-PRGP showing cytogenetic and biological characteristics of the radial growth phase of acral melanomas.
Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.
FoxO3a preferentially induces p27Kip1 expression while impairing muscle precursor cell-cycle progression.
G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2.
Loss of Rb and Myc activation co-operate to suppress cyclin D1 and contribute to transformation.
Molecular targeting of VEGF/VEGFR signaling by the anti-VEGF monoclonal antibody BD0801 inhibits the growth and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.
Oncostatin M induces growth arrest of skeletal muscle cells in G1 phase by regulating cyclin D1 protein level.
Overexpressed cyclin D1 protein related to p53 and retinoblastoma proteins in transitional cell carcinoma of the urinary tract.
p16, retinoblastoma (pRb), and cyclin D1 protein expression in human endometriotic and adenomyotic lesions.
Proproliferative phenotype of pulmonary microvascular endothelial cells.
Redox regulation of the G1 to S phase transition in the mouse embryo fibroblast cell cycle.
Retinoic acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation.
Rho-kinase regulates negatively the epidermal growth factor-stimulated colon cancer cell proliferation.
Selective repression of the oncogene cyclin D1 by the tumor suppressor miR-206 in cancers.
The ATM and ATR inhibitors CGK733 and caffeine suppress cyclin D1 levels and inhibit cell proliferation.
The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway.
The protein-tyrosine phosphatase SHP-2 is required during angiotensin II-mediated activation of cyclin D1 promoter in CHO-AT1A cells.
Rinderpest
A carboxy terminal domain of the L protein of rinderpest virus possesses RNA triphosphatase activity - The first enzyme in the viral mRNA capping pathway.
Sarcoma
Expression profile and molecular genetic regulation of cyclin D1 expression in epithelioid sarcoma.
Sexually Transmitted Diseases
Atomic Structure of the Trichomonas vaginalis Double-Stranded RNA Virus 2.
Squamous Cell Carcinoma of Head and Neck
A genotype-phenotype examination of cyclin D1 on risk and outcome of squamous cell carcinoma of the head and neck.
An immunohistochemical study of cyclin D1 protein expression in laryngeal squamous cell carcinoma.
Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma.
Cyclin D1 in oral premalignant lesions and oral squamous cell carcinoma: An immunohistochemical study.
Cyclin D1 overexpression associated with activation of STAT3 in oral carcinoma patients from South India.
p16INK4a Impairs Homologous Recombination-Mediated DNA Repair in Human Papillomavirus-Positive Head and Neck Tumors.
Starvation
Regulation of cyclin D1 by calpain protease.
Stomach Neoplasms
Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer.
Immunohistochemical expression of cell-cycle proteins in gastric precancerous lesions.
Thyroid Cancer, Papillary
Cyclin D1 protein expression in human thyroid gland and thyroid cancer.
Thyroid Neoplasms
CCND1 Splice Variant as A Novel Diagnostic and Predictive Biomarker for Thyroid Cancer.
Cyclin D1 protein expression in human thyroid gland and thyroid cancer.
Trichomonas Infections
Atomic Structure of the Trichomonas vaginalis Double-Stranded RNA Virus 2.
Tumor Virus Infections
Identification and DNA sequence of the large subunit of the capping enzyme from Shope fibroma virus.
Urinary Bladder Neoplasms
Investigation of the Inhibitory Effect of Platycodin D in Human Transitional Cell Carcinoma Cell Line 5637.
Uterine Cervical Neoplasms
Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus.
Expression Of Cyclin D1 Protein Isoforms And Its Prognostic Significance In Cervical Cancer.
Vaccinia
A carboxy terminal domain of the L protein of rinderpest virus possesses RNA triphosphatase activity - The first enzyme in the viral mRNA capping pathway.
A cellular factor is required for transcription of vaccinia viral intermediate-stage genes.
A general method for rapid and cost-efficient large-scale production of 5' capped RNA.
A nuclease that cuts specifically in the ribosome binding site of some T4 mRNAs.
A temperature-sensitive lesion in the small subunit of the vaccinia virus-encoded mRNA capping enzyme causes a defect in viral telomere resolution.
An RNA 5'-triphosphatase related to the protein tyrosine phosphatases.
Analysis of a temperature-sensitive vaccinia virus mutant in the viral mRNA capping enzyme isolated by clustered charge-to-alanine mutagenesis and transient dominant selection.
Analysis of RNA binding by the dengue virus NS5 RNA capping enzyme.
Bacterio-opsin mRNA in wild-type and bacterio-opsin-deficient Halobacterium halobium strains.
Biochemical analysis of the multifunctional vaccinia mRNA capping enzyme encoded by a temperature sensitive virus mutant.
Bromouridine triphosphate inhibits transcription termination and mRNA release by vaccinia virions.
Capping-RACE: a simple, accurate, and sensitive 5' RACE method for use in prokaryotes.
Catalytic activity of vaccinia mRNA capping enzyme subunits coexpressed in Escherichia coli.
Characteristics of reactions catalyzed by purified guanylyltransferase from vaccinia virus.
Characterization of human, Schizosaccharomyces pombe, and Candida albicans mRNA cap methyltransferases and complete replacement of the yeast capping apparatus by mammalian enzymes.
Characterization of the Trypanosoma brucei 5S ribosomal RNA gene and transcript: the 5S rRNA is a spliced-leader-independent species.
Characterization of the vaccinia virus RNA 5'-triphosphatase and nucleotide triphosphate phosphohydrolase activities. Demonstrate that both activities are carried out at the same active site.
Complete nucleotide sequence of reovirus L2 gene and deduced amino acid sequence of viral mRNA guanylyltransferase.
Construction of a synthetic messenger RNA encoding a membrane protein.
Covalent catalysis in nucleotidyl transfer. A KTDG motif essential for enzyme-GMP complex formation by mRNA capping enzyme is conserved at the active sites of RNA and DNA ligases.
Crystal structure of vaccinia virus mRNA capping enzyme provides insights into the mechanism and evolution of the capping apparatus.
Discontinuous DNA replication of Drosophila melanogaster is primed by octaribonucleotide primer.
Discrete functional stages of vaccinia virus early transcription during a single round of RNA synthesis in vitro.
DNA-dependent ATPase activity associated with vaccinia virus early transcription factor.
Domain structure of the vaccinia virus mRNA capping enzyme. Expression in Escherichia coli of a subdomain possessing the RNA 5'-triphosphatase and guanylyltransferase activities and a kinetic comparison to the full-size enzyme.
Domain structure of vaccinia virus mRNA capping enzyme. Activity of the Mr 95,000 subunit expressed in Escherichia coli.
Effects of alanine cluster mutations in the D12 subunit of vaccinia virus mRNA (guanine-N7) methyltransferase.
Efficient preparation and properties of mRNAs containing a fluorescent cap analog: Anthraniloyl-m(7)GpppG.
Entirely plasmid-based reverse genetics system for rotaviruses.
Evidence that discontinuous DNA replication in Escherichia coli is primed by approximately 10 to 12 residues of RNA starting with a purine.
Factor-dependent transcription termination by vaccinia RNA polymerase. Kinetic coupling and requirement for ATP hydrolysis.
Factor-dependent transcription termination by vaccinia virus RNA polymerase. Evidence that the cis-acting termination signal is in nascent RNA.
Functional domains of vaccinia virus mRNA capping enzyme. Analysis by limited tryptic digestion.
Genetic analysis of poxvirus mRNA cap methyltransferase: suppression of conditional mutations in the stimulatory D12 subunit by second-site mutations in the catalytic D1 subunit.
Histidine codons appended to the gene encoding the RPO22 subunit of vaccinia virus RNA polymerase facilitate the isolation and purification of functional enzyme and associated proteins from virus-infected cells.
Identification of a single transcriptional initiation site for the glutamic tRNA and COB genes in yeast mitochondria.
Identification of multiple transcriptional initiation sites on the yeast mitochondrial genome by in vitro capping with guanylyltransferase.
Identification of the DNA sequences encoding the large subunit of the mRNA-capping enzyme of vaccinia virus.
Identification of the vaccinia virus mRNA guanyltransferase active site lysine.
Improved translation efficiency of therapeutic mRNA.
Inhibition of vaccinia RNA guanine 7-methyltransferase by compounds designed as multisubstrate adducts.
Interaction and mutual stabilization of the two subunits of vaccinia virus mRNA capping enzyme coexpressed in Escherichia coli.
Intrinsic RNA (guanine-7) methyltransferase activity of the vaccinia virus capping enzyme D1 subunit is stimulated by the D12 subunit. Identification of amino acid residues in the D1 protein required for subunit association and methyl group transfer.
Location of the S-adenosyl-L-methionine binding region of the vaccinia virus mRNA (guanine-7-)methyltransferase.
Mapping the active site of vaccinia virus RNA triphosphatase.
Mechanism of mRNA capping by vaccinia virus guanylyltransferase: characterization of an enzyme--guanylate intermediate.
Mechanism of the mRNA guanylyltransferase reaction: isolation of N epsilon-phospholysine and GMP (5' leads to N epsilon) lysine from the guanylyl-enzyme intermediate.
Methyltransferase and subunit association domains of vaccinia virus mRNA capping enzyme.
Modification of RNA by mRNA guanylyltransferase and mRNA (guanine-7-)methyltransferase from vaccinia virions.
mRNA guanylyltransferase and mRNA (guanine-7-)-methyltransferase from vaccinia virions. Donor and acceptor substrate specificites.
Multicopy suppressors of temperature-sensitive mutations of yeast mRNA capping enzyme.
Multiple proteins and subgenomic mRNAs may be derived from a single open reading frame on tobacco mosaic virus RNA.
Mutational analysis of mRNA capping enzyme identifies amino acids involved in GTP binding, enzyme-guanylate formation, and GMP transfer to RNA.
Mutational analysis of the RNA triphosphatase component of vaccinia virus mRNA capping enzyme.
Mutational analysis of the Saccharomyces cerevisiae ABD1 gene: cap methyltransferase activity is essential for cell growth.
Mutational analysis of yeast mRNA capping enzyme.
Phenotypic analysis of a temperature sensitive mutant in the large subunit of the vaccinia virus mRNA capping enzyme.
Phylogeny of mRNA capping enzymes.
Poxvirus mRNA cap methyltransferase. Bypass of the requirement for the stimulatory subunit by mutations in the catalytic subunit and evidence for intersubunit allostery.
Preparation of Functional, Fluorescently Labeled mRNA Capped with Anthraniloyl-m(7)GpppG.
Purification and characterization of a GTP-pyrophosphate exchange activity from vaccinia virions. Association of the GTP-pyrophosphate exchange activity with vaccinia mRNA guanylyltransferase . RNA (guanine-7-)methyltransferase complex (capping enzyme).
Purification and characterization of a transcription termination factor from vaccinia virions.
Purification and use of vaccinia virus messenger RNA capping enzyme.
Purification of mRNA guanylyltransferase and mRNA (guanine-7-) methyltransferase from vaccinia virions.
Purification of mRNA guanylyltransferase from vaccinia virions.
Reaction in alphavirus mRNA capping: formation of a covalent complex of nonstructural protein nsP1 with 7-methyl-GMP.
Regulation of herpesvirus macromolecular synthesis: transcription-initiation sites and domains of alpha genes.
RNA binding properties of vaccinia virus capping enzyme.
RNA capping by HeLa cell RNA guanylyltransferase. Characterization of a covalent protein-guanylate intermediate.
RNA capping by the vaccinia virus guanylyltransferase. Structure of enzyme-guanylate intermediate.
Sedimentation of an RNA polymerase complex from vaccinia virus that specifically initiates and terminates transcription.
Structural Basis of Poxvirus Transcription: Transcribing and Capping Vaccinia Complexes.
Structural insights into the mechanism and evolution of the vaccinia virus mRNA cap N7 methyl-transferase.
Structure and stability of mRNA synthesized by vaccinia virus-encoded bacteriophage T7 RNA polymerase in mammalian cells. Importance of the 5' untranslated leader.
Structure of human PIR1, an atypical dual-specificity phosphatase.
Structure-function analysis of the mRNA cap methyltransferase of Saccharomyces cerevisiae.
Structure-function analysis of the triphosphatase component of vaccinia virus mRNA capping enzyme.
Structure-function analysis of vaccinia virus mRNA cap (guanine-N7) methyltransferase.
Synthesis of mRNA guanylyltransferase and mRNA methyltransferases in cells infected with vaccinia virus.
The broad spectrum antiviral nucleoside ribavirin as a substrate for a viral RNA capping enzyme.
The D1 and D12 subunits are both essential for the transcription termination factor activity of vaccinia virus capping enzyme.
The LEF-4 subunit of baculovirus RNA polymerase has RNA 5'-triphosphatase and ATPase activities.
The mRNA (guanine-7-)methyltransferase domain of the vaccinia virus mRNA capping enzyme. Expression in Escherichia coli and structural and kinetic comparison to the intact capping enzyme.
The vaccinia virus mRNA (guanine-N7-)-methyltransferase requires both subunits of the mRNA capping enzyme for activity.
Tracking and elimination of an interfering polypeptide coexpressed with the vaccinia virus mRNA capping enzyme overproduced in Escherichia coli.
Transcription initiation factor activity of vaccinia virus capping enzyme is independent of mRNA guanylylation.
Transcriptional initiation and 5' termini of yeast mitochondrial RNA.
Transcriptional initiation and processing of the small ribosomal RNA of yeast mitochondria.
Utilization of the guanylyltransferase and methyltransferases of vaccinia virus to modify and identify the 5'-terminals of heterologous RNA species.
Vaccinia virus capping enzyme is a transcription initiation factor.
Vaccinia virus gene D12L encodes the small subunit of the viral mRNA capping enzyme.
Vaccinia virus mRNA (guanine-7-)methyltransferase: mutational effects on cap methylation and AdoHcy-dependent photo-cross-linking of the cap to the methyl acceptor site.
Yeast and viral RNA 5' triphosphatases comprise a new nucleoside triphosphatase family.
Yeast-based genetic system for functional analysis of poxvirus mRNA cap methyltransferase.
[A plasmid-based reverse genetics system for rotaviruses].
Vesicular Stomatitis
A dual-functional priming-capping loop of rhabdoviral RNA polymerases directs terminal de novo initiation and capping intermediate formation.
Formation of guanosine(5')tetraphospho(5')adenosine cap structure by an unconventional mRNA capping enzyme of vesicular stomatitis virus.
The large protein 'L' of Peste-des-petits-ruminants virus exhibits RNA triphosphatase activity, the first enzyme in mRNA capping pathway.
Unique capping activity of the recombinant RNA polymerase (L) of vesicular stomatitis virus: association of cellular capping enzyme with the L protein.
Virus Diseases
Physical interaction of RTBV ORFI with D1 protein of Oryza sativa and Fe/Zn homeostasis play a key role in symptoms development during rice tungro disease to facilitate the insect mediated virus transmission.
Synthesis of mRNA guanylyltransferase and mRNA methyltransferases in cells infected with vaccinia virus.
Ubiquitin-dependent proteolysis of cyclin D1 is associated with coxsackievirus-induced cell growth arrest.
Whooping Cough
Protease-activated receptor (PAR)-independent growth and pro-inflammatory actions of thrombin on human cultured airway smooth muscle.
Yellow Fever
Murine Efficacy and Pharmacokinetic Evaluation of the Flaviviral NS5 Capping Enzyme 2-Thioxothiazolidin-4-One Inhibitor BG-323.